Nordicus Partners Reports $2.3M Quarterly Loss, Cash Drops to $5,784, and Discloses $600K Convertible Note
NORD has more than doubled off its 52-week low of $1.25 on elevated volume (1.9× avg).
Summary
Nordicus Partners' Q1 FY2027 10-Q shows cash down to $5,784, a $2.3M net loss, ineffective disclosure controls, and a going-concern warning. A subsequent $600K convertible note provides runway but with onerous terms.
Key Events · Earnings and Guidance · NORD
-
Cash Position Collapses
Cash fell to $5,784 at June 30, 2026, from $20,878 at March 31, 2026, while operating activities used $159,844 during the quarter.
-
Net Loss Driven by Non-Cash Investment Markdown
Net loss of $2.31 million included a $1.49 million non-cash decrease in the fair value of the Mag Mile Capital investment; operating loss was $819,624.
-
Going Concern and Control Weaknesses Reaffirmed
Management states substantial doubt about the company's ability to continue as a going concern, and the CEO concluded disclosure controls were not effective as of June 30, 2026.
-
Subsequent $600K Convertible Note
On September 10, 2026, the company issued a $600,000 Convertible Grid Promissory Note to Keystone Capital Partners, receiving $500,000 cash and issuing 250,000 commitment shares; the note matures June 10, 2027, with a 120% prepayment premium and conversion at 90% of VWAP after default.
Analysis · NORD · Trade & Services
The pre-revenue biotech's cash position collapsed to just $5,784 at quarter-end, down from $20,878 three months earlier, while the company burned $159,844 in operations. The quarter's $2.31 million net loss was driven largely by a $1.49 million non-cash markdown of its Mag Mile Capital investment, not operating deterioration. Management again states substantial doubt about its ability to continue as a going concern, and the CEO concluded disclosure controls were ineffective due to limited finance resources. The subsequent $600,000 convertible note from Keystone Capital Partners (with $500,000 cash received) provides a short-term lifeline but carries a 120% prepayment premium and conversion at 90% of VWAP after default, terms that could prove costly if the company cannot raise additional capital.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 34.7% of the 1013 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.50%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NORD was trading at $3.52 on OTC in the Trade & Services sector, with a market capitalization of approximately $67.8M. The 52-week trading range was $1.25 to $10.16. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.